Pharmacological perioperative brain neuroprotection: A qualitative review of randomized clinical trials

British Journal of Anaesthesia

Volumn 110, Issue SUPPL.1, 2013, Pages

  Bilotta, F ^a   Gelb, A W ^b   Stazi, E ^a   Titi, L ^a   Paoloni, F P ^c   Rosa, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GIMEMA Foundation   (Italy)

Author keywords

brain neuroprotection; ketamine; lidocaine; magnesium sulphate; perioperative cerebral damage; perioperative stroke; postoperative cognitive decline

Indexed keywords

ASPARTIC ACID; ATORVASTATIN; ERYTHROPOIETIN; ESTRADIOL; GANGLIOSIDE GM1; GLUTAMIC ACID; KETAMINE; LEXIPAFANT; LIDOCAINE; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENT; NIMODIPINE; PEGORGOTEIN; PIRACETAM; PROPOFOL; REMACEMIDE; RIVASTIGMINE; THIOPENTAL; XENON;

ANESTHESIA INDUCTION; ARTICLE; CONTINUOUS INFUSION; HEART SURGERY; HUMAN; INCIDENCE; META ANALYSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COGNITIVE DYSFUNCTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT DURATION; VASCULAR SURGERY;

EID: 84878545040     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet059     Document Type: Article

References (52)

1. Silverstein JH, Timberger M, Reich DL, Uysal S. Central nervous system dysfunction after noncardiac surgery and anesthesia in the elderly. Anesthesiology 2007; 106: 622-8
2. Carrascal Y, Guerrero AL. Neurological damage related to cardiac surgery. Neurologist 2010; 16: 152-64
3. Ng JL, Chant MT, Gelb AW. Perioperative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology 2011; 115: 879-90
4. Selim M. Perioperative stroke. N Engl J Med 2007; 356: 706-13
5. Newman MF, Kirchner JL, Phillips-Bute B, Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395-402
6. Mashour GA, Shannks AM, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology 2011; 114: 1289-96
7. McKhann GM, Goldsborough MA, Borowicz LM Jr,et al. Cognitive outcome after coronary artery bypass: a one-year prospective study. Ann Thorac Surg 1997; 63: 510-5
8. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet 1998; 351: 861
9. Bateman BT, Schumacher HC, Wang S, Shaefi S, Berman MF. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors and outcomes. Anesthesiology 2009; 110: 231-8
10. Erol DD, Ibis HA. Glutamate/aspartate supplementation during cardiopulmonary bypass: effect on postoperative neurocognitive function. Heart Surg Forum 2008; 11: E17-20
11. Forsman M, Tubylewicz Olsnes B, Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth 1990; 65: 514-20
12. Grieco G, D'Hollosy M, Culliford AT, Saran J. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Stroke 1996; 27: 858-74
13. Haljan G, Maitland A, Buchan A, et al. The erythropoietin neuroprotective effect assessment in CABG surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial. Stroke 2009; 40: 2769-75
14. Hudetz JA, Iqbal Z, Gandhi SD, et al. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand 2009; 53: 864-72
15. Kanbak M, Saricaoglu F, Avci A, Ocal T, Koray Z, Aypar U. Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100b protein levels. Can J Anaesth 2004; 51: 712-7
16. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thor Surg 1999; 67: 1117-24
17. Butterworth J, Legault C, Stump DA, et al. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1999; 13: 690-4
18. Arrowsmith JE, Harrison DM, Newman SP. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 1998; 29: 2357-62
19. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-76
20. Holinski S, Claus B, Alaaraj N, et al. Cerebroprotective effect of piracetam in patients undergoing coronary bypass surgery. Med Sci Monit 2008; 14: PI53-7
21. Hocker J, Stapelfeldt C, Leiendecker J, et al. Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a doubleblinded randomized controlled pilot study. Anesthesiology 2009; 110: 1068-76
22. Legault C, Furberg CD, Lynne E, et al. Nomidipine neuroprotection in cardiac valve replacement. Stroke 1996; 27: 593-8
23. Mack WJ, Kellner CP, Sahlein DH, et al. Intraoperative magnesium infusion during carotid endarterectomy: a double-blind placebocontrolled trial. J Neurosurg 2009; 110: 961-7
24. Mitchell SJ, Merry AF, Frampton C, et al. Cerebral protection by lidocaine during cardiac operations: a follow-up study. Ann Thorac Surg 2009; 87: 820-5
25. Nagels W, Demeyere R, Van Hemelrijck J, Vandenbussche E, Gijbels K, Vandermeersch E. Evaluation of the neuroprotection effects of S(+)-ketamine during open-heart surgery. Anesth Analg 2004; 98: 1595-603
26. Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986; 64: 140-2
27. Taggart DP, Browne SM, Wade DT, Halligan PW. Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist. Heart 2003; 89: 897-900
28. Wang D, Wu X, Li J, Xiao F, Liu X, Meng M. The effect of lidocaine early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg 2002; 95: 1134-41
29. Gamberini M, Bolliger D, Lurati Buse GA, et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med 2009; 37: 1762-8
30. Hogue CW Jr, Freedland K, Hershey T, et al. Neurocognitive outcomes are not improved by 17b-estradiol in postmenopausal women undergoing cardiac surgery. Stroke 2007; 38: 2048-54
31. Bhudia SK, Cosgrove DM, Naugle RI, et al. Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2006; 131: 853-61
32. Mathew JP, Mackensen GB, Phillips-Bute B, et al. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke 2009; 40: 880-7
33. Roach GW, Newman MF, Murkin JM, et al. Multicenter Study of Perioperative Ischemia (MsSPI). Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Anesthesiology 1999; 99: 1255-64
34. Zaidan JR, Klochany A, Martin WM, Ziegler JS, Harless DM, Andrews RB. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology 1991; 74: 406-11
35. Bilotta F, Doronzio A, Stazi E, et al. Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis. J Alzheimers Dis 2010; 22: 81-9
36. Mantz J, Degos V, Laigle C. Recent advance in pharmacologic neuroprotection. Eur J Anaesthesiol 2010; 27: 6-10
37. Hall R, Murdoch J. Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection. Can J Anaesth 1990; 37: 762-77
38. Gelb AW, Bayona NA, Wilson JX, Cechetto DF. Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 2002; 96: 1183-90
39. Yang Q, Dong H, Deng J, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen speciesmediated up-regulation of antioxidant enzymes in rats. Anesth Analg 2011; 112: 931-7
40. Koerner IP, Brambrink AM. Brain protection by anesthetic agents. Curr Opin Anaesthesiol 2006; 19: 481-6
41. Schifilliti D, Grasso G, Conti A, Fodale V. Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS Drugs 2010; 24: 893-907
42. Brown WR, Moody DM, Challa VR. Cerebral fat embolism from cardiopulmonary bypass. J Neuropathol Exp Neurol 1999; 58: 109-19
43. Grogan K, Stearns J, Hogue CW. Brain protection in cardiac surgery. Anesthesiol Clin 2008; 26: 521-38
44. Rees K, Beranek-Stanley M, Burke M, Ebrahim S. Hypothermia to reduce neurological damage following coronary artery bypass surgery. Cochrane Database Syst Rev 2001: CD002138. doi:10.1002/14651858.CD002138
45. Todd MM, Hindman BJ, Clarke WR, Toner JC. Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005; 352: 135-45
46. Bouchard D, Carrier M, Demers P, et al. Statin in combination with b-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg 2011; 91: 654-9
47. Mackensen GB, Gelb AW. Postoperative cognitive deficits: more questions than answers. Eur J Anaesthesiol 2004; 21: 85-8
48. Motallebzadeh R, Jahangiri M. The effect of the dynamic air bubble trap on cerebral microemboli and S100 beta. J Thor Cardiovasc Surg 2004; 128: 154
49. Monk TG, Weldon C, Garvan CW, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108: 18-30
50. Gladstone D, Black S, Hakim A; Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Towards wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33: 2123-36
51. Murkin J, Newman S, Stump D, Blumenthal JA. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 1995; 59: 1289-95
52. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996; 335: 1857-63